AREC — Arecor Therapeutics Share News
0.000.00%
- £29.26m
- £27.55m
- £5.05m
REG - Arecor Therapeutics - Co-Development Agreement & Monetisation Deal
AnnouncementREG - Arecor Therapeutics - Interim results for the six months to 30 June 2025
AnnouncementREG - Arecor Therapeutics - Notice of Interim Results
AnnouncementREG - Arecor Therapeutics - Positive FDA Feedback on Phase 2 Study Design
AnnouncementREG - Arecor Therapeutics - Holding(s) in Company
AnnouncementREG - Arecor Therapeutics - Change of Auditor
AnnouncementRCS - Arecor Therapeutics - Arecor Establishes New Scientific Advisory Board
AnnouncementREG - Arecor Therapeutics - Grant of Options and PDMR Dealing
AnnouncementREG - Arecor Therapeutics - Result of AGM
AnnouncementREG - Arecor Therapeutics - Non-Executive Director Board Change
AnnouncementREG - Arecor Therapeutics - Director/PDMR Dealing
AnnouncementREG - Arecor Therapeutics - Arecor Partnership with Skye Bioscience
AnnouncementREG - Arecor Therapeutics - Director Dealing
AnnouncementREG - Arecor Therapeutics - Arecor sells rights to non-Ogluo® products
AnnouncementREG - Arecor Therapeutics - Posting of 2024 Annual Report and Notice of AGM
AnnouncementRCS - Arecor Therapeutics - Arecor to present on Investor Meet Company
AnnouncementREG - Arecor Therapeutics - Grant of Options and PDMR Dealing
AnnouncementREG - Arecor Therapeutics - Final results for 2024
AnnouncementREG - Arecor Therapeutics - Notice of Results
Announcement